Latest News

Recursion raises $239M in Series D, partners with lead investor Bayer


The partnership includes a $30 million upfront payment from Bayer and potentially more than $100 million in milestones per program generated through the partnering of the German drugmaker’s molecule library and Recursion’s artificial intelligence-based drug discovery platform.

Source link

Related posts

The human response to indoor air quality and the significance of the olf and decipol units

Newsemia

Opinion: The emergence of laboratory benefits managers: PBM déjà vu?

Newsemia

Samenvatting: Axonics® ontvangt Technology Innovation Award van Medtech Insight

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World